Characterization of CRISPR Technologies using TXTL and the Echo Liquid Handler

Speakers:
Vincent Noireaux, PhD, Professor, University of Minnesota
Aset Khakimzhan, PhD Student, University of Minnesota
This webinar is part two of a two-part series on abstract cell-free expression.
In the last decade, CRISPR technologies have revolutionized molecular biology. In this webinar, we show how prototyping CRISPR components can be accelerated by combining a cell-free transcription and translation (TXTL) system with an Echo Acoustic Liquid Handler (LH) from Beckman Coulter Life Sciences.
This presentation covers:
Overview of TXTL and its applications
How accelerated prototyping can be used to test sgRNAs, new CRISPR, and anti-CRISPR proteins
Overview and specifications of Echo LH
The speed and resource savings enabled by the Echo LH in a TXTL lab
Echo LH and TXTL to characterize CRISPR enzymes and anti-CRISPR proteins
Echo LH and TXTL to uncover fundamentals of target recognition
Application of the Echo LH to accelerate CRISPR based genetic circuits
Learn more: becls.co/3A599hW
MAPSS Approval Code: 21.07.2129.AUTO
Disclaimer: These products are not intended or validated for use in the diagnosis of disease or other conditions. © 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. Echo and Access are trademarks or registered trademarks of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company. All other trademarks are the property of their respective owners.